These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27006378)

  • 21. Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population.
    Adonis MI; Díaz J; Miranda VR; Chahuan M; Zambrano A; Benitez HC; Campos M; Avaria P; Urzúa U; Marín P; Gohurdett M; Cisterna Y; Gil L
    Biol Res; 2014 Nov; 47(1):62. PubMed ID: 25723567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of bronchial intraepithelial neoplasia and early lung cancer of the central airways: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Wisnivesky JP; Yung RC; Mathur PN; Zulueta JJ
    Chest; 2013 May; 143(5 Suppl):e263S-e277S. PubMed ID: 23649442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-step evolution of lung cancer.
    Braithwaite KL; Rabbitts PH
    Semin Cancer Biol; 1999 Aug; 9(4):255-65. PubMed ID: 10448113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection and screening of lung cancer.
    Mascaux C; Peled N; Garg K; Kato Y; Wynes MW; Hirsch FR
    Expert Rev Mol Diagn; 2010 Sep; 10(6):799-815. PubMed ID: 20843203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of central airway lung cancer in smokers with silicosis.
    Lo AI; Huang Y; Lam SY; Cheung AH; Au R; Leung CC; Lam WK; Ip MS; Chan-Yeung M; Lam B
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):523-7. PubMed ID: 21396213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
    Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
    Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a transgenic mouse model to identify markers of human lung tumors.
    Linnerth NM; Sirbovan K; Moorehead RA
    Int J Cancer; 2005 May; 114(6):977-82. PubMed ID: 15645424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular changes track recurrence and progression of bronchial precancerous lesions.
    Sozzi G; Oggionni M; Alasio L; Conte D; Tavecchio L; Pilotti S; Spinelli P; Calarco G
    Lung Cancer; 2002 Sep; 37(3):267-70. PubMed ID: 12234694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
    Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
    Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for lung cancer: Who should be screened?
    Jett J
    Arch Pathol Lab Med; 2012 Dec; 136(12):1511-4. PubMed ID: 23194043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments and advances in secondary prevention of lung cancer.
    Rizzo S; Del Grande F; Wannesson L; Froesch P; Giannetto G; Petrella F
    Eur J Cancer Prev; 2020 Jul; 29(4):321-328. PubMed ID: 32452945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer].
    Guo H; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):307-11. PubMed ID: 27215460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of preneoplasia: lessons from lung cancer.
    Wistuba II
    Curr Mol Med; 2007 Feb; 7(1):3-14. PubMed ID: 17311529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.
    Pass HI; Beer DG; Joseph S; Massion P
    Thorac Surg Clin; 2013 May; 23(2):211-24. PubMed ID: 23566973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.
    Mao L; Hruban RH; Boyle JO; Tockman M; Sidransky D
    Cancer Res; 1994 Apr; 54(7):1634-7. PubMed ID: 8137272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions.
    McWilliams A; MacAulay C; Gazdar AF; Lam S
    Oncogene; 2002 Oct; 21(45):6949-59. PubMed ID: 12362276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of autofluorescence bronchoscopy in patients with laryngeal cancer.
    Cetınkaya E; Veyseller B; Yildirim YS; Aksoy F; Ozgül MA; Gençoğlu A; Altin S
    J Laryngol Otol; 2011 Feb; 125(2):181-7. PubMed ID: 21059279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A translational view of the molecular pathogenesis of lung cancer.
    Sato M; Shames DS; Gazdar AF; Minna JD
    J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.